Overview

combretastatins


Show Summary Details

Quick Reference

A family of compounds, originally derived from the African bush willow tree Combretum caffrum, used in cancer chemotherapy where they inhibit tumour vascularization by binding to tubulin in endothelial cells. Synthetic variants are emerging with slightly different efficacy. Combretastatin A-4 is the most potent naturally occurring combretastatin and is currently (2009) in clinical trials as a combination therapy with carboplatin and paclitaxel for thyroid carcinoma.

Subjects: Medicine and Health.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.